Eric Houpt is an Infectious Disease physician affiliated with University of Virginia. OpenAlex indexes 373 publications with 22,548 citations (h-index 73); ClinicalTrials.gov lists 2 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Infectious Disease profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1300 Jefferson Park Ave
Charlottesville, VA 229033363
Telephone
434-982-1700Provider last certified this registry record 10 Aug 2023.
Clinical trials
- Multidrug Resistant Shigella Infection in Bangladesh
Sponsor: University of Virginia
- DNA Sequencing of MDR TB in Eastern Siberia
Sponsor: University of Virginia
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
94.6%Macrolide Antimicrobial33%Azithromycin100%Part D≥17 patientsAntimycobacterial26.9%Ethambutol Hcl100%Part D≥15 patients+ 3 more classes in this area
Metabolism & gastrointestinal
5.4%Proton pump inhibitor5.4%Pantoprazole Sodium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
15 NIH research awards on record, funded 2003–2025 per NIH RePORTER. The latest:
- Mycobacterial Lung Diseases in Virginia: sequencing and clinical determinants of relapse and outcome
University of Virginia
FY2025$589,122R01HL155547 - Mycobacterial Lung Diseases in Virginia: sequencing and clinical determinants of relapse and outcome
University of Virginia
FY2024$578,396R01HL155547 - Mycobacterial Lung Diseases in Virginia: sequencing and clinical determinants of relapse and outcome
University of Virginia
FY2023$673,634R01HL155547
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Charles Landen, MD
University of Virginia
Stephen Caldwell
University of Virginia
James Platts-Mills, MD
University of Virginia
Eugene Barrett, MD
University of Virginia
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”